The statement is - False.
In the pre-industrial societies, the economy was far from being based on providing information and services. The economy was largely based on two things, agriculture and trade.
The agriculture was the basis and the dominant sector in the pre-industrial economy. The more agricultural products a nation had, the more it had to trade, thus becoming wealthy. This can easily be seen in the colonies that the European countries had in the pre-industrial period, where every inch of the land that was suitable for agriculture was used, and latter those products were shipped and traded in order to become wealthier.
The most common reason driving why some FRGs remain vibrant and successful while others struggle to exist is the different leadership styles among FRGs. FRG stands for Family Readiness Group. Hope this is the answer that you are looking for. Have a great day!<span />
Double-blind design: this is how the study will be conducted. This means that in this study, participants will know which treatments are being applied to each participant. In this case, the researcher can hire a doctor or health professional who can deliver the different treatments to the participants without the researcher and the participants themselves knowing what treatment is being delivered and which participants are not receiving any treatment.
Antagonist: It will be a substance used to establish connections in the participants' neurological receptors, but without activating these receptors and preventing any other substance from activating them.
Acetylcholine: Will be the neurotransmitter tested in treatments, as it is the main neurotransmitter often related to the symptoms of Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia
Positron Emission Tomography (PET): It will allow the visualization of images that will allow the evaluation of the functioning of the neurotransmitters related to each tested treatment.
Blood-brain barrier: It will allow the assessment of the metabolic function of the participants' brain, as it protects the nervous system from toxic and harmful substances. This cerebral metabolic function will be evaluated in relation to each treatment applied.
Myelin sheath: is the protective layer of nerve cells. It is usually damaged in people who have Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia, for this reason, it will allow the assessment of their protection in relation to each treatment tested.
